CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 24 enrolled
Drug / intervention
XperGuide +1 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02021071
NCT02021071N/ACompleted
CompareCT.gov

Evaluation of Adding Virtual Path Planning to the Philips FD20 XperGuide to Reduce Radiation Dose During Image-guided Needle Interventional Procedures.

Philips Clinical & Medical Affairs Global·observational·Posted Dec 27, 2013·Updated Mar 16, 2022

In Brief

An observational study evaluating XperGuide and XperGuide with virtual path planning for Gastrointestinal Diseases and 4 related conditions. Completed, enrolled 24 participants across 1 site.

Detailed Summary

Philips Healthcare has added a virtual path planner to the current commercially available XperGuide software platform and that has the potential to significantly reduce dose during image-guided needle interventions.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGastrointestinal Diseases, Bone Diseases, Muscular Diseases, Spinal Diseases, Vascular Diseases
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 27, 2013
Enrollment StartDec 1, 2013
Primary CompletionJun 1, 2014
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 12.5 years ago

Interventions

XperGuideradiation

Live 3D image needle guidance which overlays live fluoroscopy and 3D soft tissue imaging data from previous acquired CT, MR or XperCT.

XperGuide with virtual path planningradiation

Instrument guidance allowing certain tasks that would normally occur using continuous X-ray guidance to be performed with reduced dose for patient and staff.